New Non-Implanted device aims to ease overactive bladder woes

NCT ID NCT06885099

Completed Symptom relief Sponsor: FemPulse Corporation Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether women with overactive bladder (OAB) could easily use the FemPulse System, a non-implanted vaginal electrical stimulation device. Eleven women with OAB symptoms used the device and completed a survey about its usability. The goal was simply to see if the system is user-friendly, not to measure how well it treats OAB.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FemPulse System (non-implanted vaginal electrical stimulation device)
What this could lead to: If successful, this device could offer a simple, drug-free option for women to manage overactive bladder symptoms at home.
What could go wrong: This was a very small, completed study (11 people) focused only on ease of use, not on how well the device treats symptoms. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER (OAB) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

overactive bladder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVERACTIVE BLADDER (OAB)

Contacts and locations

Locations

Holy Cross Women's Hospital

Fort Lauderdale, Florida, 33334, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.